Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 31

Trial Status

Completed1
Terminated1

Role Distribution

Other Roles2

Activity Timeline

Clinical Trials (2)

NCT05785819Phase 2Terminated
A Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia
Heparin Induced ThrombocytopeniaThrombocytopenia, Immune
StudychairStart date: 2023-09-26
NCT02025621Phase 3Completed
Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass
Coronary Artery Bypass GraftingLow Cardiac Output SyndromeMitral Valve Surgery
Studychair

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Rajendra Mehta, MD

Duke Clinical Research Institute

Moderately Similar
1 trials

Shared therapeutic areas:

Coronary Artery BypassLow Cardiac Output SyndromeMitral Valve Surgery

Worked with same sponsors:

Tenax Therapeutics, Inc.
Collaborated on 1 trial
Similarity Score34%

Nigel Key, MD

University of North Carolina, Chapel Hill

Related
4 trials

Shared therapeutic areas:

Heparin Induced ThrombocytopeniaPurpura, Thrombocytopenic, Idiopathic
Similarity Score12%

Susan F Assmann, PhD

Carelon Research

Related
3 trials

Shared therapeutic areas:

Heparin Induced ThrombocytopeniaPurpura, Thrombocytopenic, Idiopathic
Similarity Score12%

David Kuter, MD

Massachusetts General Hospital

Related
5 trials

Shared therapeutic areas:

Heparin Induced ThrombocytopeniaPurpura, Thrombocytopenic, Idiopathic
Similarity Score12%

Judith Lin, MD

Brigham and Women's Hospital

Related
3 trials

Shared therapeutic areas:

Heparin Induced ThrombocytopeniaPurpura, Thrombocytopenic, Idiopathic
Similarity Score12%

Cindy Leissinger, MD

Tulane University

Related
4 trials

Shared therapeutic areas:

Heparin Induced ThrombocytopeniaPurpura, Thrombocytopenic, Idiopathic
Similarity Score12%

Thomas Ortel, MD

Duke University

Related
4 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, Idiopathic
Similarity Score6%

James Bussel, MD

Weill Medical College, Cornell University

Related
2 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, Idiopathic
Similarity Score6%

Emmanouil s Brilakis, MD, PhD

North Texas Veterans Healthcare System

Related
10 trials

Shared therapeutic areas:

Coronary Artery Bypass
Similarity Score6%

Thomas Raife, MD

University of Iowa

Related
3 trials

Shared therapeutic areas:

Heparin Induced Thrombocytopenia
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT05785819Phase 2StudyChair

A Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia

Heparin Induced ThrombocytopeniaThrombocytopenia, Immune
Terminated
NCT02025621Phase 3StudyChair

Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass

Coronary Artery Bypass GraftingLow Cardiac Output SyndromeMitral Valve Surgery
Completed

All 2 trials loaded